Publications: Dr Sabarinath Vallath
Reader CS, Vallath S, Steele CW, Haider S, Brentnall A, Desai A, Moore KM, Jamieson NB et al.
(
2019
)
.
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
.
The Journal of Pathology
vol.
249
,
(
3
)
332
-
342
.
Kolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S et al.
(
2018
)
.
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
.
eLife
vol.
7
,
Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A et al.
(
2017
)
.
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
.
Molecular Therapy
vol.
25
,
(
10
)
2427
-
2427
.
Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A et al.
(
2017
)
.
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
.
Molecular Therapy
vol.
25
,
(
1
)
259
-
273
.
Vallath S, Reader C, Morton J, Sansom O, Evans J, Biankin A, Barry ST, Kocher H et al.
(
2016
)
.
Abstract B53: The integrin αvβ6 is a promising therapeutic target for treating PDAC
.
Cancer Research
.
vol.
76
,
b53
-
b53
.
Agrawal T, Chan W-Y, Sage E, Kolluri K, Sladen P, Sturges G, Vallath S, Janes S et al.
(
2016
)
.
Epithelial ErbB2 activity determines thymus homeostasis and T cell maturation
.
The Journal of Immunology
vol.
196
,
(
1_Supplement
)
194.11
-
194.11
.
Whilding LM, Vallath S, Maher J
(
2016
)
.
The integrin αvβ6: a novel target for CAR T-cell immunotherapy?
.
Biochemical Society Transactions
vol.
44
,
(
2
)
349
-
355
.
Vallath S, Sage EK, Kolluri KK, Lourenco SN, Teixeira VS, Chimalapati S, George PJ, Janes SM et al.
(
2016
)
.
CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
.
Scientific Reports
vol.
6
,
(
1
)
Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic R, Violette S, Ghaem-Maghami S, Vallath S et al.
(
2016
)
.
Abstract B129: Chimeric antigen receptor T-cells targeting the αvβ6 integrin demonstrate potent antitumor activity in multiple solid tumors
.
Cancer Immunology Research
.
vol.
4
,
b129
-
b129
.
Reader CS, Vallath S, Morton J, Steele C, Kocher HM, Keyse SM, Sansom O, Marshall JF
(
2015
)
.
Abstract B87: Cell lines generated from PDAC transgenic mice reveal integrin αvβ6 modifies the invasive phenotype of pancreatic cancer
.
Cancer Research
.
vol.
75
,
b87
-
b87
.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.
(
2014
)
.
Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer
.
Molecular Cancer Research
vol.
11
,
(
10_Supplement
)
b046
-
b046
.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.
(
2014
)
.
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
.
Journal of the National Cancer Institute
vol.
106
,
(
8
)
Vallath S, Gadaletta E, Chelala C, Scarpa A, Hart IR, Kocher HM, Marshall JF
(
2012
)
.
Abstract B42: Toward targeting integrin αvβ6 for the therapy of pancreatic cancer
.
Conference:
Therapyb42
-
b42
.
(
2014
)
.
Correction
.
Thorax
vol.
69
,
(
3
)
Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A
(
2014
)
.
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
.
European Respiratory Journal
vol.
44
,
(
2
)
513
-
522
.
Vallath S, Sage E, Teixeira V, Janes S, Giangreco A
(
2013
)
.
S130 Role of CADM1 in squamous cell carcinoma progression
.
Thorax
vol.
68
,
(
Suppl 3
)
Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallath S, Payne SJ, Gomm JJ, Dreger SA et al.
(
2013
)
.
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence
.
Clin Cancer Res
vol.
20
,
(
2
)
344
-
357
.
Coughlan L, Vallath S, Gros A, Giménez-Alejandre M, Van Rooijen N, Thomas GJ, Baker AH, Cascalló M et al.
(
2012
)
.
Combined Fiber Modifications Both to Target αvβ6 and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles In Vivo but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5
.
Human Gene Therapy
vol.
23
,
(
9
)
960
-
979
.
Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, Upile T, Kalavrezos N et al.
(
2011
)
.
Stromal features are predictive of disease mortality in oral cancer patients
.
J Pathol
vol.
223
,
(
4
)
470
-
481
.
Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S, Vallath S, Nitch‐Smith H et al.
(
2011
)
.
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell‐surface marker of the basal phenotype that promotes tumour cell invasion
.
The Journal of Pathology
vol.
223
,
(
5
)
646
-
658
.
Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, Upile T, Kalavrezos N et al.
(
2011
)
.
Stromal features are predictive of disease mortality in oral cancer patients
.
The Journal of Pathology
vol.
223
,
(
4
)
470
-
481
.
Marsh D, Suchak K, Moutasim K, Vallath S, Hopper C, Jerjes W, Upile T, Kalavrezos N et al.
(
2011
)
.
Stromal features are predictive of disease mortality in oral cancer patients
.
J Pathol
vol.
4
,
(
223
)
470
-
481
.
Wagstaff JL, Vallath S, Marshall JF, Williamson RA, Howard MJ
(
2010
)
.
Two-dimensional heteronuclear saturation transfer difference NMR reveals detailed integrin αvβ6 protein – peptide interactions
.
Chemical Communications
vol.
46
,
(
40
)
7533
-
7535
.
Saha A, Ellison D, Thomas GJ, Vallath S, Mather SJ, Hart IR, Marshall JF
(
2010
)
.
High‐resolution in vivo imaging of breast cancer by targeting the pro‐invasive integrin αvβ6
.
The Journal of Pathology
vol.
222
,
(
1
)
52
-
63
.
Filipović A, Gronau JH, Green AR, Wang J, Vallath S, Shao D, Rasul S, Ellis IO et al.
(
2010
)
.
Biological and clinical implications of nicastrin expression in invasive breast cancer
.
Breast Cancer Research and Treatment
vol.
125
,
(
1
)
43
-
53
.
Jones J, Allen M, Thomas G, Dawoud M, Vallath S, Payne S, Edwards D, Pennington C et al.
(
2009
)
.
DCIS-Associated Myoepithelial Cells Expressing the αvβ6 Integrin Modify Tumour Cell Behaviour: A Predictor of Invasive Progression?
.
Cancer Research
vol.
69
,
(
24_Supplement
)
4159
-
4159
.
Coughlan L, Vallath S, Saha A, Flak M, McNeish IA, Vassaux G, Marshall JF, Hart IR et al.
(
2009
)
.
In Vivo Retargeting of Adenovirus Type 5 to αvβ6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
.
Journal of Virology
vol.
83
,
(
13
)
6416
-
6428
.